BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 168349)

  • 1. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.
    Banerjee SP; Snyder SH; Mechoulam R
    J Pharmacol Exp Ther; 1975 Jul; 194(1):74-81. PubMed ID: 168349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes.
    Bloom AS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):97-103. PubMed ID: 6278139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some structural requirements for inhibition of high-affinity synaptosomal serotonin uptake by cannabinoids.
    Johnson KM; Dewey WL; Harris LS
    Mol Pharmacol; 1976 May; 12(3):345-52. PubMed ID: 934055
    [No Abstract]   [Full Text] [Related]  

  • 6. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Alterations in dopamine uptake in rat corpus striatum induced by combinations of stress and delta8-tetrahydrocannabinol (delta8-THC).
    Littleton JM; Maclean KI; Brownlee G
    Br J Pharmacol; 1976 Mar; 56(3):370P. PubMed ID: 1260199
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice.
    Efthimiopoulos S; Giompres P; Valcana T
    J Neurosci Res; 1991 Aug; 29(4):510-9. PubMed ID: 1838778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
    Tseng LF; Menon MK; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of Na and Cl ions in retaining noradrenaline and serotonin in the meso-diencephalic region of the rat brain and in the action of gamma-aminobutyric acid on that process].
    Esaian NA; Armenian AR; Demirchian AA; Arakelian LN; Chiflikian MD
    Vopr Biokhim Mozga; 1975; 10():129-36. PubMed ID: 136798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: The effect of delta-tetrahydrocannabinol (delta-thc) on dopamine metabolism in the rat corpus striatum: the influence of environment.
    Littleton JM; Maclean KI
    Br J Pharmacol; 1974 May; 51(1):117P. PubMed ID: 4441767
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
    Murphy LL; Steger RW; Smith MS; Bartke A
    Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
    Raiteri M; Bonanno G; Marchi M; Maura G
    J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of delta9-tetrahydrocannabinol on the conversion of [3H]trypotphan to 5-[3H] hydroxytryptamine in the mouse brain.
    Johnson KM; Dewey WL
    J Pharmacol Exp Ther; 1978 Oct; 207(1):140-50. PubMed ID: 702335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional changes in monoamine content and uptake of the rat brain during postnatal development.
    Nomura Y; Naitoh F; Segawa T
    Brain Res; 1976 Jan; 101(2):305-15. PubMed ID: 1244975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 2. In vitro studies on monoamine uptake inhibition and uptake impairment.
    Björklund A; Horn AS; Baumgarten HG; Nobin A; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():29-60. PubMed ID: 1064286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.